There were 1,390 press releases posted in the last 24 hours and 351,051 in the last 365 days.

mRNA Treatment Market | Exclusive Report on Current Scenario and Future Opportunities to 2030

mRNA Treatment Market

mRNA Treatment Market

mRNA Treatment Market Segmentation

mRNA Treatment Market Segmentation

The Global mRNA Treatment market size is expected to grow at a compound annual growth rate (CAGR) of 21.2% from 2022 to 2030 | Reveal InsightAce Analytic

JERSEY, NJ, US, January 24, 2023 / -- InsightAce Analytic Pvt. Ltd. announced the publication of a market research report titled "Global mRNA Treatment Market - By Product Type (Prophylactic vaccines, Therapeutic vaccines, Therapeutic drugs), Therapeutic Area (Infectious Diseases, Oncological Disorders, Other Disorders), Route of Administration (Intravenous, Intramuscular, Intranasal, Others))- Market Outlook and Industry Analysis 2030" According to company's newest research, the Global mRNA Treatment Market is predicted grow rapidly during forecast period, with a promising CAGR of 21.2% between 2022 and 2030.

Top Key Players Covered in this Report are:

The prominent market players include CureVac, Moderna, BioNTech (Pfizer), Translate Bio, Ethris (AstraZeneca), Stemirna Therapeutics Co., Ltd., Kernal Biologics, Silence Therapeutics, eTheRNA (Etherna ImmunotherapiesIn-Cell-Art, Skyhawk Therapeutics, Inc., Anima Biotech, H3 Biomedicine Inc., Arcturus Therapeutics, eFFECTOR Therapeutics, Inc., ), Tiba Biotechnology, Ionis Pharmaceuticals, Inc., RNAimmune (Sirnaomics), miRagen Therapeutics, Inc., Ziphius Therapeutics NV, GlaxoSmithKline plc, Other Prominent Players.

Get Free Sample Copy of the Report @

mRNA, also known as messenger RNA, is a molecule that contains the instructions or recipe that instructs cells to produce a protein. mRNA vaccines function by introducing a fragment of mRNA that corresponds to a viral protein, typically a short fragment of a protein present on the virus's outer membrane. The two mRNA treatments, mRNA therapeutics and mRNA vaccines have become promising alternatives to traditional treatment methods. There are several types of mRNA immunotherapy in development right now. One such strategy is the creation of personalized cancer vaccinations. It enables scientists to develop mRNA cancer vaccines that stimulate the immune system to target cancer cells. This entails employing genomic sequencing to find neoepitope mutations in a patient's cancer cells.

Traditional vaccines use inactivated microorganisms to stimulate the body's immunological response. mRNA vaccines employ genetically modified molecules that instruct your cells to produce a harmless protein fragment from a specific virus. This causes the immune system to produce antibodies tailored to attack and destroy the viral protein. Recent technological advances in stability, translation, and delivery have made messenger RNAs a possible therapeutic tool. Indeed, mRNA vaccines have opened up new pharmacological domains and become a leading therapeutic class. These mRNA vaccines help build next-generation vaccines.

The mRNA treatment industry is driven by the rising occurrence of cancer, viral infections, and genetic abnormalities. In addition, increasing vaccination awareness fuels the worldwide mRNA industry. In addition, the use of mRNA to create viral antigen proteins within the cell is one of the most promising treatments for viral illness. For example, as a result of the COVID-19 outbreak, the number of businesses performing clinical trials for vaccine development is anticipated to generate profitable prospects soon.

Get Customized Report @

Increased investments by operational players in developing innovative and effective medicines and vaccines are expected to promote market growth throughout the forecast period. For example, in June 2022, Pfizer and Valneva announced the completion of an equity investment for the research and commercialization of prophylactic vaccinations for infectious diseases.

The high cost of studies, the risk of failure, and the difficulties connected with measuring mRNA are expected to limit industry expansion. The slow process of FDA approvals and long-term clinical trials are also responsible for market growth limitations.

North America represents the greatest share of the worldwide mRNA treatment market due, among other factors, to the growing demand to produce transformational treatments, increasing funding infusions, a favourable regulatory environment, and a massively increased focus on establishing precision medicine.

Key Market Developments:

• In Sept 2022, Biomedical Advanced Research and Development Authority (BARDA) awarded Arcturus Therapeutics up to $63.2 million to expand its existing influenza vaccine programme to include the development of a pandemic influenza vaccine based on its patented self-amplifying mRNA technology.

• In June 2022, Pfizer and BioNTech formed a new research, development, and marketing collaboration to produce the world's first mRNA-based vaccine to prevent shingles (herpes zoster virus) (HZV). The partnership builds on the success of the firms' authorized mRNA Covid-19 vaccine.

• In Apr 2022, Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 from Arcturus announced that the Phase 3 study met the primary efficacy endpoint.

• In Sept 2021, Sanofi completed its $3.2 billion acquisition of mRNA therapies developer Translate Bio. mRNA Center of Excellence intends to harness the potential of next-generation mRNA vaccines and other crucial areas, including immunology, cancer, and rare disorders.

Market Segmentation:

Global mRNA Treatment Market, by Product Type, 2022-2030 (Value US$ Mn)

• Prophylactic Vaccines
• Therapeutic Vaccines
• Therapeutic Drugs

Global mRNA Treatment Market, by Therapeutic Area, 2022-2030 (Value US$ Mn)

• Infectious Diseases
• Oncological Disorders
• Other Disorders

Global mRNA Treatment Market, by the Route of Administration, 2022-2030 (Value US$ Mn)

• Intravenous
• Intramuscular
• Intranasal
• Others

Global mRNA Treatment Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America mRNA Treatment Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe mRNA Treatment Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific mRNA Treatment Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America mRNA Treatment Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa mRNA Treatment Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Read Report @

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the mRNA Treatment Market.
 To receive an industry overview and future trends of the mRNA Treatment Market.
 To analyze the mRNA Treatment Market drivers and challenges.
 To get information on the global mRNA Treatment Market size (Value US$ Mn) forecast to 2030.
 Noteworthy investments, mergers & acquisitions in the global mRNA Treatment Market industry

Other Related Reports Published by InsightAce Analytic:

Global mRNA Synthesis and Manufacturing Services Market
Global mRNA Synthesis Raw Materials Market
Global mRNA Extraction and Purification Market
Global Lipid Nanoparticles (LNPs) CDMO Market
Global Advanced Therapy Medicinal Products CDMO Market

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Visit Website:
Follow Us on LinkedIn @
Subscribe Our Business Newsletters:

Priyanka Tilekar
Insightace Analytic Pvt. Ltd.
+1 551-226-6109
email us here